Fundraising Fox

Theianova

4 employees on LinkedIn · 1 known investors

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

Founders & leadership

CG
Colin GreenChief Scientific Officer
CFCarissa Fonseca
Carissa FonsecainChief Executive Officer
PAPriyanka Agarwal
Priyanka AgarwalinDirector of Research & Operations, Formulation Lead

Investors · 1

Frequently asked questions

What does Theianova do?
TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.
Who founded Theianova?
Theianova was founded by Colin Green.
Who are Theianova's investors?
Theianova's investors include Bridgewest Ventures.